Description
New oncology reimbursements in Belgium
Article: New oncology reimbursements in Belgium
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in urologic cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart
